We only have this paper's title and publication details.
Read it at the sourceTargeting SLK with ASO reduces tumor growth and glycolysis, suggesting therapeutic potential.
SLK-targeting ASO inhibits tumor growth and glycolysis
No takes yet. Share an insight, caveat, or question.
Chen et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: